<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04092855</url>
  </required_header>
  <id_info>
    <org_study_id>2019-2527</org_study_id>
    <nct_id>NCT04092855</nct_id>
  </id_info>
  <brief_title>Right Ventricular Pressure Waveform Monitoring in Cardiac Surgery</brief_title>
  <acronym>PACEPORT</acronym>
  <official_title>Early Identification and Prediction of Right Ventricular Dysfunction and Failure in Critically Ill Patients: An Observational Non-Interventional Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Montreal Heart Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Edwards Lifesciences</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Montreal Heart Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      RV dysfunction has been associated with increased mortality in the ICU and cardiac surgical
      patients. Thus, early identification of RV dysfunction at less severe stages will allow for
      earlier intervention and potentially better patient outcomes.

      However, so far, no studies have reported prospectively the prevalence of abnormal RV
      pressure waveform during cardiac surgery and in the ICU. The investigator's primary
      hypothesis is that the prevalence of abnormal RV pressure waveform occurs in more than 50% of
      cardiac surgical patients throughout their hospitalization. Those patients with abnormal RV
      pressure waveform will be more prone to post-operative complications related to RV
      dysfunction and failure in the OR and ICU.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Right ventricular (RV) dysfunction is mostly associated to a decrease in contractility, right
      ventricular pressure overload or right ventricular volume overload. RV dysfunction can occur
      in a number of clinical scenarios in the intensive care unit (ICU) and operating room (OR):
      pulmonary embolism, acute respiratory distress syndrome (ARDS), septic shock, RV infarction,
      and in pulmonary hypertensive patients undergoing cardiac surgery.

      Unfortunately, identifying which patients will develop RV dysfunction and then progress
      towards RV failure have proven difficult. One of the reasons for delaying the diagnosis of RV
      dysfunction could be the lack of uniform definition, especially in the perioperative period.
      Echocardiographic definitions of RV dysfunction have been described: RV fractional area
      change (RVFAC) &lt; 35 %, tricuspid annular plane systolic excursion (TAPSE) &lt; 16 mm, tissue
      Doppler S wave velocity &lt;10 cm/s, RV ejection fraction (RVEF) &lt;45% and RV dilation. However,
      echocardiographic indices alone are insufficient in describing RV function. The diagnosis of
      fulminant RV failure is more easily recognised as a combination of echocardiographic
      measures, compromised hemodynamic measures and clinical presentation. RV dysfunction is
      inevitably associated with absolute or relative pulmonary hypertension because of the
      anatomic and physiological connection between the RV and pulmonary vascular system. The gold
      standard for measuring pulmonary pressure is still the pulmonary artery catheter. However, RV
      output can initially be preserved despite of pulmonary hypertension. It is therefore
      mandatory that early, objective, continuous, easily obtainable and subclinical indices of RV
      dysfunction are found and validated to initiate early treatment of this disease.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 10, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of abnormal diastolic RV waveforms before CPB, after CPB and in the ICU</measure>
    <time_frame>From thermodilution catheter insertion until 2 hours after ICU arrival</time_frame>
    <description>Abnormal RV pressure waveform will be defined as a difference between the RV end-diastolic minus the early-diastolic pressure &gt; 4 mmHg.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients with difficult and complex separation from cardiopulmonary bypass at the end of cardiac surgery</measure>
    <time_frame>From the discontinuation of cardiopulmonary bypass until ICU arrival after surgery, assessed up to 4 hours.</time_frame>
    <description>Difficult separation from cardiopulmonary bypass: instability requiring at least two different types of pharmacological agents (i.e., inotropes ± vasopressors ± inhaled agents) Complex separation from cardiopulmonary bypass: Hemodynamic instability requiring return on cardiopulmonary bypass or addition of mechanical support (intra-aortic balloon pump or extra-corporeal membrane oxygenator)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative time of Persistent Organ Dysfunction or Death (TPOD) during the first 28 days after cardiac surgery</measure>
    <time_frame>Up to 28 days or until hospital discharge</time_frame>
    <description>TPOD is a continuous variable representative of the burden of care and morbidity during the first 28 days following cardiac surgery and was chosen to circumvent issues arising for using other clinical endpoint such as ICU length of stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of deaths during hospitalisation</measure>
    <time_frame>Up to 30 days or until hospital discharge</time_frame>
    <description>Death from any cause</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of acute kidney injury (AKI)</measure>
    <time_frame>Up to 28 days or until hospital discharge</time_frame>
    <description>Acute kidney injury (AKI) according to KDIGO serum creatinine criteria:
Stage 1: ≥50% or 27 umol/L increases in serum creatinine, Stage 2: ≥100% increase in serum creatinine, Stage 3 ≥200% increase in serum creatinine or an increase to a level of ≥254 umol/L or dialysis initiation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of major bleeding</measure>
    <time_frame>Up to 28 days or until hospital discharge</time_frame>
    <description>Major bleeding is defined by the Bleeding Academic Research Consortium (BARC) as one of the following:
Perioperative intracranial bleeding within 48h
Reoperation after closure of sternotomy for the purpose of controlling bleeding
Transfusion of ≥5 units of whole blood of packed red blood cells within a 48 hours period
Chest tube output ≥2L within a 24 hours period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of surgical reintervention for any reasons</measure>
    <time_frame>Up to 28 days or until hospital discharge</time_frame>
    <description>Re-operation after the initial surgery for any cause</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of deep sternal wound infection or mediastinitis</measure>
    <time_frame>Up to 28 days or until hospital discharge</time_frame>
    <description>Diagnosis of a deep incisional surgical site infection or mediastinitis by a surgeon or attending physician</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of delirium</measure>
    <time_frame>Up to 28 days or until hospital discharge</time_frame>
    <description>Delirium is defined as an intensive care delirium screening checklist (ICDSC) score(18) of ≥4 in the week following surgery or positive result for the Confusion Assessment Method for the ICU (CAM-ICU).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of stroke</measure>
    <time_frame>Up to 28 days or until hospital discharge</time_frame>
    <description>Central neurologic deficit persisting longer than 72 hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total duration of ICU stay in hours</measure>
    <time_frame>Up to 28 days or until hospital discharge</time_frame>
    <description>Number of hours passed in the ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of vasopressor requirements (in hours)</measure>
    <time_frame>Up to 28 days or until hospital discharge</time_frame>
    <description>Vasopressors include norepinephrine, epinephrine, dobutamine, vasopressin, phenylephrine, milrinone, isoproterenol and dopamine.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of hospital stay (in days)</measure>
    <time_frame>Up to 28 days or until hospital discharge</time_frame>
    <description>Number of days hospitalized from the day of surgery to discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of mechanical ventilation (in hours)</measure>
    <time_frame>Up to 28 days or until hospital discharge</time_frame>
    <description>A duration of &gt;24 hours will be considered prolonged ventilation requirements.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of major morbidity or mortality</measure>
    <time_frame>Up to 28 days or until hospital discharge</time_frame>
    <description>Including death, prolonged ventilation, stroke, renal failure (Stage ≥2), deep sternal wound infection and reoperation for any reason.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Right ventricular ejection fraction</measure>
    <time_frame>From arrival to the operating room until 2 hours after ICU arrival</time_frame>
    <description>Assessed by the American Society of Echocardiography guidelines</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Right ventricular fractional area change</measure>
    <time_frame>From arrival to the operating room until 2 hours after ICU arrival</time_frame>
    <description>Assessed by the American Society of Echocardiography guidelines</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Right ventricular strain</measure>
    <time_frame>From arrival to the operating room until 2 hours after ICU arrival</time_frame>
    <description>Assessed by the American Society of Echocardiography guidelines</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tricuspid annular plane systolic excursion</measure>
    <time_frame>From arrival to the operating room until 2 hours after ICU arrival</time_frame>
    <description>Assessed by the American Society of Echocardiography guidelines</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Right ventricular performance index</measure>
    <time_frame>From arrival to the operating room until 2 hours after ICU arrival</time_frame>
    <description>Assessed by the American Society of Echocardiography guidelines</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Portal flow pulsatility fraction</measure>
    <time_frame>From arrival to the operating room until 2 hours after ICU arrival</time_frame>
    <description>Defined as the difference between the maximal and the minimal velocity during the cardiac cycle divided by the maximal velocity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Right ventricular stroke work index</measure>
    <time_frame>From arrival to the operating room until 2 hours after ICU arrival</time_frame>
    <description>0.0136x Stroke volume index x (Mean pulmonary artery pressure-mean right atrial pressure)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relative pulmonary pressure</measure>
    <time_frame>From arrival to the operating room until 2 hours after ICU arrival</time_frame>
    <description>The ratio of the mean systemic arterial pressure divided by the mean pulmonary artery pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Right ventricular function index</measure>
    <time_frame>From arrival to the operating room until 2 hours after ICU arrival</time_frame>
    <description>Defined as (isovolumic contraction time + isovolumic relaxation time)/RV ejection time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary artery pulsatility index (PAPi)</measure>
    <time_frame>From arrival to the operating room until 2 hours after ICU arrival</time_frame>
    <description>Defined as (systolic pulmonary artery pressure - diastolic pulmonary artery pressure)/central venous pressure]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compliance of the pulmonary artery (CPA)</measure>
    <time_frame>From arrival to the operating room until 2 hours after ICU arrival</time_frame>
    <description>Stroke volume divided by the pulmonary artery pulse pressure (systolic minus the diastolic pulmonary artery pressure)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulsatility of femoral venous flow</measure>
    <time_frame>From arrival to the operating room until 2 hours after ICU arrival</time_frame>
    <description>Velocity variations of blood flow in the femoral vein during the cardiac cycle</description>
  </secondary_outcome>
  <enrollment type="Anticipated">112</enrollment>
  <condition>Right Ventricular Dysfunction</condition>
  <condition>Right Heart Failure</condition>
  <condition>Congestive Heart Failure</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients undergoing cardiac surgery.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        -Male or female patients, age 18 and older, undergoing cardiac surgery and receiving
        standard of care monitoring utilizing a pulmonary artery catheter.

        Exclusion Criteria:

          -  Emergency surgery or inability to obtain consent

          -  Concomitant diseases such as pericardial constriction, congenital heart disease,
             severe valvular regurgitation, right ventricular systolic dysfunction, or right
             ventricular infarction.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andre Denault, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Montreal Heart Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sophie Robichaud, RRT</last_name>
    <phone>5143763330</phone>
    <phone_ext>3305</phone_ext>
    <email>sophie.robichaud@icm-mhi.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Samuel Côté, RRT</last_name>
    <phone>5143763330</phone>
    <phone_ext>4262</phone_ext>
    <email>samuel.cote@icm-mhi.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Montreal Heart Institute</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H1T 1C8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophie Robichaud, RRT</last_name>
      <phone>5143763330</phone>
      <phone_ext>3305</phone_ext>
      <email>sophie.robichaud@icm-mhi.org</email>
    </contact>
    <contact_backup>
      <last_name>Samuel Cote, RRT</last_name>
      <phone>5143763330</phone>
      <phone_ext>4262</phone_ext>
      <email>samuel.cote@icm-mhi.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Haddad F, Doyle R, Murphy DJ, Hunt SA. Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure. Circulation. 2008 Apr 1;117(13):1717-31. doi: 10.1161/CIRCULATIONAHA.107.653584. Review.</citation>
    <PMID>18378625</PMID>
  </reference>
  <reference>
    <citation>Denault AY, Bussières J, Carrier M, Mathieu P, and the DSBSG. The importance of difficult separation from cardiopulmonary bypass: the Montreal and Quebec Heart Institute experience. Exp Clin Cardiol. 2006;11 (1):37.</citation>
  </reference>
  <reference>
    <citation>Denault AY, Bussières JS, Arellano R, Finegan B, Gavra P, Haddad F, Nguyen AQ, Varin F, Fortier A, Levesque S, Shi Y, Elmi-Sarabi M, Tardif JC, Perrault LP, Lambert J. A multicentre randomized-controlled trial of inhaled milrinone in high-risk cardiac surgical patients. Can J Anaesth. 2016 Oct;63(10):1140-53. doi: 10.1007/s12630-016-0709-8. Epub 2016 Jul 28.</citation>
    <PMID>27470232</PMID>
  </reference>
  <reference>
    <citation>Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010 Jul;23(7):685-713; quiz 786-8. doi: 10.1016/j.echo.2010.05.010.</citation>
    <PMID>20620859</PMID>
  </reference>
  <reference>
    <citation>Raymond M, Grønlykke L, Couture EJ, Desjardins G, Cogan J, Cloutier J, Lamarche Y, L'Allier PL, Ravn HB, Couture P, Deschamps A, Chamberland ME, Ayoub C, Lebon JS, Julien M, Taillefer J, Rochon A, Denault AY. Perioperative Right Ventricular Pressure Monitoring in Cardiac Surgery. J Cardiothorac Vasc Anesth. 2019 Apr;33(4):1090-1104. doi: 10.1053/j.jvca.2018.08.198. Epub 2018 Aug 25. Review.</citation>
    <PMID>30269893</PMID>
  </reference>
  <reference>
    <citation>Haddad F, Couture P, Tousignant C, Denault AY. The right ventricle in cardiac surgery, a perioperative perspective: I. Anatomy, physiology, and assessment. Anesth Analg. 2009 Feb;108(2):407-21. doi: 10.1213/ane.0b013e31818f8623. Review.</citation>
    <PMID>19151264</PMID>
  </reference>
  <reference>
    <citation>Naeije R, Manes A. The right ventricle in pulmonary arterial hypertension. Eur Respir Rev. 2014 Dec;23(134):476-87. doi: 10.1183/09059180.00007414. Review.</citation>
    <PMID>25445946</PMID>
  </reference>
  <reference>
    <citation>Denault AY, Chaput M, Couture P, Hébert Y, Haddad F, Tardif JC. Dynamic right ventricular outflow tract obstruction in cardiac surgery. J Thorac Cardiovasc Surg. 2006 Jul;132(1):43-9.</citation>
    <PMID>16798301</PMID>
  </reference>
  <reference>
    <citation>Denault A, Lamarche Y, Rochon A, Cogan J, Liszkowski M, Lebon JS, Ayoub C, Taillefer J, Blain R, Viens C, Couture P, Deschamps A. Innovative approaches in the perioperative care of the cardiac surgical patient in the operating room and intensive care unit. Can J Cardiol. 2014 Dec;30(12 Suppl):S459-77. doi: 10.1016/j.cjca.2014.09.029. Epub 2014 Oct 5. Review.</citation>
    <PMID>25432139</PMID>
  </reference>
  <reference>
    <citation>St-Pierre P, Deschamps A, Cartier R, Basmadjian AJ, Denault AY. Inhaled milrinone and epoprostenol in a patient with severe pulmonary hypertension, right ventricular failure, and reduced baseline brain saturation value from a left atrial myxoma. J Cardiothorac Vasc Anesth. 2014 Jun;28(3):723-9. doi: 10.1053/j.jvca.2012.10.017. Epub 2013 Apr 26.</citation>
    <PMID>23623891</PMID>
  </reference>
  <reference>
    <citation>Amsallem M, Kuznetsova T, Hanneman K, Denault A, Haddad F. Right heart imaging in patients with heart failure: a tale of two ventricles. Curr Opin Cardiol. 2016 Sep;31(5):469-82. doi: 10.1097/HCO.0000000000000315. Review.</citation>
    <PMID>27467173</PMID>
  </reference>
  <reference>
    <citation>Korshin A, Grønlykke L, Nilsson JC, Møller-Sørensen H, Ihlemann N, Kjøller M, Damgaard S, Lehnert P, Hassager C, Kjaergaard J, Ravn HB. The feasibility of tricuspid annular plane systolic excursion performed by transesophageal echocardiography throughout heart surgery and its interchangeability with transthoracic echocardiography. Int J Cardiovasc Imaging. 2018 Jul;34(7):1017-1028. doi: 10.1007/s10554-018-1306-4. Epub 2018 Jan 30.</citation>
    <PMID>29383465</PMID>
  </reference>
  <reference>
    <citation>Hrymak C, Strumpher J, Jacobsohn E. Acute Right Ventricle Failure in the Intensive Care Unit: Assessment and Management. Can J Cardiol. 2017 Jan;33(1):61-71. doi: 10.1016/j.cjca.2016.10.030. Epub 2016 Nov 11. Review.</citation>
    <PMID>28024557</PMID>
  </reference>
  <reference>
    <citation>Stoppe C, McDonald B, Benstoem C, Elke G, Meybohm P, Whitlock R, Fremes S, Fowler R, Lamarche Y, Jiang X, Day AG, Heyland DK. Evaluation of Persistent Organ Dysfunction Plus Death As a Novel Composite Outcome in Cardiac Surgical Patients. J Cardiothorac Vasc Anesth. 2016 Jan;30(1):30-8. doi: 10.1053/j.jvca.2015.07.035. Epub 2015 Jul 29.</citation>
    <PMID>26847748</PMID>
  </reference>
  <reference>
    <citation>Rubenfeld GD, Angus DC, Pinsky MR, Curtis JR, Connors AF Jr, Bernard GR. Outcomes research in critical care: results of the American Thoracic Society Critical Care Assembly Workshop on Outcomes Research. The Members of the Outcomes Research Workshop. Am J Respir Crit Care Med. 1999 Jul;160(1):358-67.</citation>
    <PMID>10390426</PMID>
  </reference>
  <reference>
    <citation>Kellum JA, Lameire N; KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013 Feb 4;17(1):204. doi: 10.1186/cc11454. Review.</citation>
    <PMID>23394211</PMID>
  </reference>
  <reference>
    <citation>Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, White H. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011 Jun 14;123(23):2736-47. doi: 10.1161/CIRCULATIONAHA.110.009449.</citation>
    <PMID>21670242</PMID>
  </reference>
  <reference>
    <citation>Bergeron N, Dubois MJ, Dumont M, Dial S, Skrobik Y. Intensive Care Delirium Screening Checklist: evaluation of a new screening tool. Intensive Care Med. 2001 May;27(5):859-64.</citation>
    <PMID>11430542</PMID>
  </reference>
  <reference>
    <citation>Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990 Dec 15;113(12):941-8.</citation>
    <PMID>2240918</PMID>
  </reference>
  <reference>
    <citation>Sun LY, Chung AM, Farkouh ME, van Diepen S, Weinberger J, Bourke M, Ruel M. Defining an Intraoperative Hypotension Threshold in Association with Stroke in Cardiac Surgery. Anesthesiology. 2018 Sep;129(3):440-447. doi: 10.1097/ALN.0000000000002298. Erratum in: Anesthesiology. 2019 Feb;130(2):360.</citation>
    <PMID>29889106</PMID>
  </reference>
  <reference>
    <citation>Shahian DM, O'Brien SM, Filardo G, Ferraris VA, Haan CK, Rich JB, Normand SL, DeLong ER, Shewan CM, Dokholyan RS, Peterson ED, Edwards FH, Anderson RP; Society of Thoracic Surgeons Quality Measurement Task Force. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. Ann Thorac Surg. 2009 Jul;88(1 Suppl):S2-22. doi: 10.1016/j.athoracsur.2009.05.053.</citation>
    <PMID>19559822</PMID>
  </reference>
  <reference>
    <citation>Denault AY, Pearl RG, Michler RE, Rao V, Tsui SS, Seitelberger R, Cromie M, Lindberg E, D'Armini AM. Tezosentan and right ventricular failure in patients with pulmonary hypertension undergoing cardiac surgery: the TACTICS trial. J Cardiothorac Vasc Anesth. 2013 Dec;27(6):1212-7. doi: 10.1053/j.jvca.2013.01.023. Epub 2013 Mar 21.</citation>
    <PMID>23523254</PMID>
  </reference>
  <reference>
    <citation>Ait-Oufella H, Bourcier S, Alves M, Galbois A, Baudel JL, Margetis D, Bige N, Offenstadt G, Maury E, Guidet B. Alteration of skin perfusion in mottling area during septic shock. Ann Intensive Care. 2013 Sep 16;3(1):31. doi: 10.1186/2110-5820-3-31.</citation>
    <PMID>24040941</PMID>
  </reference>
  <reference>
    <citation>Vieillard-Baron A, Naeije R, Haddad F, Bogaard HJ, Bull TM, Fletcher N, Lahm T, Magder S, Orde S, Schmidt G, Pinsky MR. Diagnostic workup, etiologies and management of acute right ventricle failure : A state-of-the-art paper. Intensive Care Med. 2018 Jun;44(6):774-790. doi: 10.1007/s00134-018-5172-2. Epub 2018 May 9. Review.</citation>
    <PMID>29744563</PMID>
  </reference>
  <reference>
    <citation>Beaubien-Souligny W, Benkreira A, Robillard P, Bouabdallaoui N, Chassé M, Desjardins G, Lamarche Y, White M, Bouchard J, Denault A. Alterations in Portal Vein Flow and Intrarenal Venous Flow Are Associated With Acute Kidney Injury After Cardiac Surgery: A Prospective Observational Cohort Study. J Am Heart Assoc. 2018 Oct 2;7(19):e009961. doi: 10.1161/JAHA.118.009961.</citation>
    <PMID>30371304</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>April 25, 2019</study_first_submitted>
  <study_first_submitted_qc>September 16, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 17, 2019</study_first_posted>
  <last_update_submitted>July 6, 2020</last_update_submitted>
  <last_update_submitted_qc>July 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Montreal Heart Institute</investigator_affiliation>
    <investigator_full_name>Andre Denault</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Right Ventricular Pressure Waveform</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Ventricular Dysfunction</mesh_term>
    <mesh_term>Ventricular Dysfunction, Right</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

